Topical treatment of ocular surface defects: comparison of the epitheliotrophic capacity of fresh frozen plasma and serum on corneal epithelial cells in an in vitro cell culture model
- 27 April 2005
- journal article
- research article
- Published by Wiley in Transfusion Medicine
- Vol. 15 (2) , 107-113
Abstract
summary. Accelerated healing of ocular surface disorders was reported using serum for topical application. It is supposed that growth factors, fibronectin and vitamins in serum support the proliferation of corneal epithelial cells. The use of fresh frozen plasma (FFP) instead of serum is theoretically attractive, as it is more easily available from blood banks. In this study, serum and FFP were investigated for composition of epitheliotrophic factors and effect on corneal epithelial cells.Whole blood was taken from five donors. Serum and FFP were prepared, and the concentrations of epithelial growth factor (EGF), Platelet‐derived growth factor (PDGF), transforming growth factor‐β1, fibronectin and vitamin A were determined. Immortalized human corneal epithelial cells were used to investigate growth, migration and differentiation in response to both blood products.Significant differences were found regarding the mediator composition of serum and FFP. Serum rather than FFP was significantly superior in stimulating cell growth, migration and differentiation.The epitheliotrophic capacity of blood products depends upon the composition of growth factors and vitamins. Blood clotting strongly influences the growth factor pattern. The superior epitheliotrophic capacity of serum might be due to the higher concentration of proliferation mediators such as EGF and PDGF and its higher content of vitamin A.Keywords
This publication has 20 references indexed in Scilit:
- Human plasma fibronectin potentiates the mitogenic activity of platelet‐derived growth factor and complements its wound healing effectsWound Repair and Regeneration, 2003
- Autologes Serum bei sonst therapieresistenten Hornhautepitheldefekten - Prospektive Studie an den ersten 70 Augen123Klinische Monatsblätter für Augenheilkunde, 2001
- Autologous serum eyedrops for dry eyes and epithelial defects: clinical and in vitro toxicity studiesBritish Journal of Ophthalmology, 2001
- Treatment of persistent corneal epithelial defect by autologous serum applicationOphthalmology, 1999
- The Activity of Collagenase-1 Is Required for Keratinocyte Migration on a Type I Collagen MatrixJournal of Cell Biology, 1997
- Topical Fibronectin Ophthalmic Solution in the Treatment of Persistent Defects of the Corneal EpitheliumAmerican Journal of Ophthalmology, 1995
- Growth factors as survival factors: Regulation of apoptosisBioEssays, 1994
- The use of ATP bioluminescence as a measure of cell proliferation and cytotoxicityJournal of Immunological Methods, 1993
- Retinoic acid decreases the number of EGF receptors in corneal epithelium and Chang conjunctival cellsExperimental Eye Research, 1991
- Beneficial Effect of Artificial Tears Made with Autologous Serum in Patients with Keratoconjunctivitis SiccaArthritis & Rheumatism, 1984